Volume 16 , Issue 1 , July 2026
Hezha Muhammad Mirza 1 ; Mezjda Ismail Rashaan 2
1 College of medicine - University of Sulaimani
2 University of Sulaimani - College of Medicine
Background: The Breast Imaging-Reporting and Data System (BIRADS) is a crucial tool for assessing and categorizing breast lesions, particularly breast lumps.
Objective: To assess the correlation and diagnostic accuracy between clinical manifestation and ultrasound BI-RADS scoring findings with pathological findings for breast disease among women. Furthermore, it also assess the sensitivity and specificity of clinical and ultrasonographic findings in breast lesions at the Sulaimani Breast Disease Treatment Center.
Materials and Methods:
A cross-sectional study was conducted at the Sulaimani Breast Disease Treatment Center to evaluate 250 female patients with breast lesions from January 2023 to February 2025. In this study, the association between American College of Radiology - Breast Imaging-Reporting and Data System (ACR-BIRADS) results and histopathology reports were evaluated using the chi-square test.
Results: The mean age was calculated as 46.8 + 11.6 years. Amongst the total, 104 (41.6%) and 63 (24.9%) of all breast lesions were in the range of BIRADS 3 and 5, respectively. Furthermore, 133 (53.2%) of the breast lesions amongst the total 250 were malignant, with the remaining 117 (46.8%) lesions being benign on histopathology. Diagnostic accuracy, sensitivity, and specificity for ultrasound BI-RADS turned out to be 90.8%, 86.5%, and 95.7%, respectively. The correlation between the ACR-BIRADS system and histopathology results was found as highly significant.
Conclusion: High sensitivity and specificity are demonstrated by BI-RADS-guided ultrasound in differentiating benign from malignant breast tumors. While it aids early detection of malignancy and reduces unnecessary biopsies, BI-RADS cannot replace histopathology as the diagnostic gold standard.